Dietary Supplement Claims That Can Trigger FDA Enforcement
- 2 days ago
- 4 min read
What to stop saying, where brands get sloppy, and how to protect your business
If you sell dietary supplements, your biggest regulatory risk is rarely the ingredient panel. It is your claims.
The FDA does not need your product to cause harm to act. If your labeling, website, social media, Amazon listing, influencer scripts, or customer testimonials suggest your supplement can diagnose, treat, cure, mitigate, or prevent a disease, you have entered drug territory. That is where warning letters, seizures, injunctions, and “stop selling now” conversations come from.
This blog breaks down the types of supplement claims that routinely get brands into trouble, with practical guidance for staying compliant.
1) Disease claims
The fastest way to turn a supplement into an unapproved drug
A disease claim is any claim that explicitly or implicitly says your product can diagnose, treat, cure, mitigate, or prevent a disease. FDA’s regulations are clear that when supplement labeling bears a disease claim, the product is treated as a drug under the law.
High-risk phrases include:
“Treats depression”
“Lowers blood pressure”
“Reverses insulin resistance”
“Reduces arthritis inflammation”
“Prevents Alzheimer’s”
“Stops migraines”
“Heals leaky gut” (often treated like disease related depending on context)
The FDA has repeatedly issued warning letters to companies marketing supplements with disease claims, including claims tied to mental health and cardiovascular disease. Important reality check:You do not have to use the words “treat” or “cure” to create a disease claim. If your marketing strongly implies your product addresses a disease or abnormal condition, the FDA can still view it as a drug claim.
2) Structure or function claims done wrong
Allowed category, but heavily misunderstood
Structure or function claims can be permissible for dietary supplements when properly written. These claims describe how a nutrient or ingredient supports the normal structure or function of the body, or general well-being, without referencing disease.
Examples that are generally in the structure or function lane:
“Supports immune health”
“Helps maintain healthy cholesterol already within the normal range”
“Promotes relaxation and restful sleep”
“Supports joint mobility”
But structure or function claims come with requirements that brands often forget.
The DSHEA disclaimer requirement
If you make a qualifying structure or function claim, the label must include the DSHEA disclaimer stating FDA has not evaluated the claim and that the product is not intended to diagnose, treat, cure, or prevent any disease. The FDA has recently reinforced expectations for how that disclaimer must be placed relative to the claim.
The 30-day notification requirement
When you use certain structure or function claims, you generally need to notify the FDA within 30 days after first marketing the product bearing the claim.
Brands miss this all the time, especially when claims are added later on a website or in an Amazon refresh that marketing treats like “not really labeling.” FDA often disagrees.
3) “Health claims” without FDA authorization
A compliance trap that looks like a marketing win
A “health claim” is different from a structure or function claim. It links a substance to reduced risk of a disease, and many health claims require FDA authorization before they can be used.
If your label copy is drifting into “reduces risk of” language, do not assume it is safe because it feels scientific. Health claims are one of those areas where the rules matter more than your intentions.
4) Testimonials and reviews that imply disease treatment
Yes, they can be your liability too
One of the most common enforcement patterns is when a brand’s official copy is cautious, but the surrounding ecosystem is reckless.
Examples:
A testimonial says your supplement “fixed my anxiety”
A before-and-after story claims it “reversed my prediabetes”
Influencer content says “this cured my eczema”
A website FAQ answers “Will this help with PCOS?” with a wink and a nod
FDA warning letters routinely cite website content and promotional statements as evidence of intended use.
If you allow disease claims to live on product pages, social captions, blog posts, or endorsed testimonials, you are effectively adopting those claims.
5) Adulteration and ingredient compliance issues that escalate enforcement
Claims get you noticed, ingredients keep you there
While claims are often the entry point, FDA also takes enforcement actions against dietary supplements it views as adulterated, including products that contain unsafe ingredients, undeclared drug ingredients, or new dietary ingredients without required notifications.
If your product category is already high scrutiny, like weight loss, sexual enhancement, bodybuilding, or blood sugar, the combination of aggressive claims plus ingredient questions is where brands get into serious trouble fast.
What FDA enforcement can look like
Warning letters are not the end of the story
A warning letter is often the first formal step, but the FDA’s enforcement toolbox includes seizure and injunction actions in appropriate cases. Translation: product can be pulled and operations can be halted.
Most brands do not get “shut down” from one minor wording mistake. They get there from repeated, obvious drug claims, refusal to correct, or continued marketing of products FDA views as unlawful.
A practical compliance checklist for your claims review
If you sell dietary supplements, these are the controls that reduce your risk:
Audit every channel
Label, website, Amazon, social media, email marketing, influencer scripts, FAQ content, and testimonials.
Separate marketing from regulatory decisions
Marketing can propose claims. Regulatory should approve claims.
Keep structure or function claims clean
No disease terms, no implied treatment, and no “diagnoses” language.
Use the DSHEA disclaimer correctly
Not hidden. Not disconnected. Not optional.
Confirm your FDA notification obligations
Especially after a relaunch or claim refresh.
Document substantiation
Truthful and non-misleading is not a vibe. You need support.
Bottom line
If your supplement marketing reads like a drug label, the FDA can treat it like a drug. The quickest way to reduce enforcement risk is to tighten your claims now, before a regulator, competitor, retailer, or plaintiff’s attorney does it for you.
If you want a clean, defensible claims framework across label and digital, Bustos Law Group helps supplement brands' review and restructure claims so you can market confidently without waking up to an FDA warning letter.
Comments